China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Coinbase Sues Three States Over Prediction Market Regulations
Dec 19, 2025 by
CPI
Walmart and PayPal Execs Say Prompts Could Trigger AI-Driven Coordination
Dec 19, 2025 by
CPI
Trump Signals New Openness to Filling Democratic Seats on SEC, CFTC, Easing Frictions Over Crypto Bill
Dec 19, 2025 by
CPI
Mexico Antitrust Authority Closes Android Competition Case After Google Commitments
Dec 18, 2025 by
CPI
LinkedIn Antitrust Settlement Faces Setback in California Court
Dec 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi